Centiva Capital, LP Fulgent Genetics, Inc. Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 12,538 shares of FLGT stock, worth $237,595. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,538
Previous 10,764
16.48%
Holding current value
$237,595
Previous $211,000
28.91%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding FLGT
# of Institutions
200Shares Held
16MCall Options Held
2.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$74.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$27.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$24.1 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$21 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$15 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $574M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...